Wockhardt

Dr Reddy’s to acquire select businesses of Wockhardt for Rs1.850 cr

13 Feb 2020

Wockhardt would transfer 62 of its brands in therapy areas such as Respiratory, Neurology, VMS, Dermatology, Gastroenterology, Pain and Vaccines as also its plant in Baddi, Himachal Pradesh along with all employees, including related sales and marketing teams to Dr Reddy’s on a slump sale basis

Wockhardt seeks shareholders' nod to raise Rs1,200 cr via NCDs

14 Jul 2016

Wockhardt’s Chikalthana plant receives GMP certificate from UK health regulator

02 Dec 2015

Wockhardt revamps quality control team on FDA demand

20 Mar 2015

Wockhardt Q2 net plunges 97% on US export ban

04 Nov 2014

FDA hits Wockhardt again; this time over Illinois plant

04 Jun 2014

Wockhardt again faces strictures from the US FDA – this time over its facility in Chicago in Illinois

FDA forces Wockhardt to withdraw yet another generic drug from US

17 May 2014

Amid mounting troubles for India’s generic drugs industry, Wockhardt Ltd is recalling over 100,000 bottles of a high blood pressure drug from the US market after they failed to meet FDA standards

Wockhardt Q3 net down 29% at Rs304 crore

10 Feb 2014

Wockhardt’s Swiss arm to list on Berne exchange today; shares spurt

19 Dec 2013

Regulatory curbs pull down Wockhardt Q2 net 69% to Rs138.50 crore

26 Oct 2013

Wockhardt faces fresh strictures from UK drug regulator

23 Oct 2013

Wockhardt recalls 5 drugs in UK after regulatory strictures

19 Oct 2013

Wockhardt gets another slap from UK drug regulator

14 Oct 2013

Wockhardt gets another blast from US drug regulator FDA

28 Sep 2013

British drug regulator recalls 16 Wockhardt drugs

11 Jul 2013

Wockhardt reports consolidated Q4 net profit of Rs334.767 crore

28 May 2013

Wockhardt to launch generic hypertension drug in US

21 Aug 2012

Wockhardt completes divestment of nutrition business to Danone

26 Jul 2012

Fortis in talks over control of Wockhardt Hospitals: report

21 May 2012

Cough up dues or face liquidation, HC tells Wockhardt

08 Sep 2011

The Bombay High Court has told drug maker Wockhardt to work out a plan and a timeframe for paying Rs350 crore dues owed to its bondholders, or face liquidation

Danone to buy Wockhardt's nutrition business for Rs1,576 crore

03 Aug 2011

To gain an entry into the world's fastest-growing infant nutrition market, French dairy major Groupe Danone is buying the nutrition business of pharmaceutical major Wockhardt for Rs1,576 crore.

Danone in talks to buy Wockhardt's nutrition business: report

26 Jul 2011

Wockhardt receives tentative US FDA approval for generic version of Patanol ophthalmic solution

01 Jul 2011

Wockhardt launches three new products in the United States

21 Jun 2011

Wockhardt receives US FDA approval for generic Alzheimer's drug

25 Apr 2011

View details about the software product Informachine News Trackers